Citation Impact
Citing Papers
Complement drives Th17 cell differentiation and triggers autoimmune arthritis
2010 StandoutNobel
Toxicities of chimeric antigen receptor T cells: recognition and management
2016
Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort
2015
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism
2009 StandoutScienceNobel
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Defining acute flares in knee osteoarthritis: a systematic review
2018
Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
2018 StandoutNobel
The Impact of Buprenorphine Transdermal Delivery System on Activities of Daily Living Among Patients With Chronic Low Back Pain
2014
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
2009
Cutaneous Wound Healing
1999 Standout
New insights into T cell biology and T cell‐directed therapy for autoimmunity, inflammation, and immunosuppression
2010
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Myeloid C-type lectins in innate immunity
2006
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
2003 Standout
The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials
2009
Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions
2009
Association Between Naproxen Use and Protection Against Acute Myocardial Infarction
2002
ADP-ribosylation Factor and Rho Proteins Mediate fMLP-dependent Activation of Phospholipase D in Human Neutrophils
1998
Rheumatoid arthritis
2016 Standout
Essential role of microRNA‐155 in the pathogenesis of autoimmune arthritis in mice
2011
Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects
2006
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
2012
Defining remission in rheumatoid arthritis: Results of an initial american college of rheumatology/european league against rheumatism consensus conference
2009
Tocilizumab – A novel therapy for non-organ-specific autoimmune diseases
2012
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients
2016
A Meta-analysis of Controlled Clinical Studies With Diacerein in the Treatment of Osteoarthritis
2006
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
2013
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
2004
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
2015
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000 Standout
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
Controlled‐Release Oxycodone and Naloxone in the Treatment of Chronic Low Back Pain: A Placebo‐Controlled, Randomized Study
2013
Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4
2017 StandoutNobel
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Identification of Collagen Fibrils in Scleroderma Skin
1988
Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
2000
Pattern Recognition Receptors and Inflammation
2010 Standout
Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs: The tocilizumab in combination with traditional disease‐modifying antirheumatic drug therapy study
2008
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Scleroderma
2009 Standout
What a difference a year makes: Reflections on the ACR recommendations for the medical management of osteoarthritis
2001
Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial
2012
Ageing and the pathogenesis of osteoarthritis
2016
Osteoarthritis
2015 Standout
Role for TNF in atherosclerosis? Lessons from autoimmune disease
2009
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
How antirheumatic drugs protect joints from damage in rheumatoid arthritis
2008
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
2003 Standout
Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee
2007
Forget personalised medicine and focus on abating disease activity
2012
Opioide bei chronischen nicht-tumorbedingten Schmerzen – sind sie Nichtopioidanalgetika überlegen?
2014
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
2010 Standout
Chondroitin and Glucosamine in the Management of Osteoarthritis: An Update
2013
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease
2016
Coxibs and Cardiovascular Disease
2004 Standout
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
2015
Graves' Ophthalmopathy
2010 Standout
Osteoarthritis
2016
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions
2015
Evidence that cytokines play a role in rheumatoid arthritis
2008
Systemic Lupus Erythematosus
2011 Standout
Buprenorphine transdermal system in adults with chronic low back pain: A randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase
2010
Signalling through C-type lectin receptors: shaping immune responses
2009
Active repression of IFN regulatory factor-1-mediated transactivation by IFN regulatory factor-4
2005
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials
2007
Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double‐blind, placebo‐controlled study
2009
Ulcerative colitis
2016 Standout
Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis
2004
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of the Extended-Release Tramadol Hydrochloride/Acetaminophen Fixed-Dose Combination Tablet for the Treatment of Chronic Low Back Pain
2013
A Comparison between Enriched and Nonenriched Enrollment Randomized Withdrawal Trials of Opioids for Chronic Noncancer Pain
2011
Opioids Compared With Placebo or Other Treatments for Chronic Low Back Pain
2014
The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study
2007
The Dectin-2 family of C-type lectin-like receptors: an update
2013
Dendritic Cells In Vivo: A Key Target for a New Vaccine Science
2008 StandoutNobel
Rheumatoid arthritis
2010 Standout
Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies
2015
Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with Rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (Ibuprofen, Diclofenac, and Nabumetone)
2002
Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials
2018
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
2009
Mechanisms and Functions of Inflammasomes
2014 Standout
Prevalence of neuropathic pain in knee or hip osteoarthritis: A systematic review and meta-analysis
2017
Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial
2001 Standout
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
2012
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
2001
A double‐blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain
2009
Keloid Fibroblasts Exhibit an Altered Response to TGF-β
1992
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis
2005
Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example
2014
Osteoarthritis
2019 Standout
Evidence for predictive validity of remission on long‐term outcome in rheumatoid arthritis: A systematic review
2009
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program
2003
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence
2007
Anemia of Chronic Disease
2005 Standout
Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure
2013
Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study
2014
Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin‐6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double‐blind, placebo‐controlled trial of tocilizumab in inadequate responders to methotrexate alone
2009
COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice
2002
Interleukin‐6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: The role of acute‐phase reactants
2010
MRI-based semiquantitative scoring of joint pathology in osteoarthritis
2013
Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule
1984 StandoutNature
Diacerein for osteoarthritis
2014
Fibronectin: current concepts of its structure and functions
1980
Risk of cardiovascular events and rofecoxib: Cumulative meta-analysis
2005
Medications for Acute and Chronic Low Back Pain: A Review of the Evidence for an American Pain Society/American College of Physicians Clinical Practice Guideline
2007
Measurement of anti-DNA antibodies: a reappraisal using five different methods.
1987
Immune Complexes in the Rheumatic Diseases
1987
Chondroitin for osteoarthritis
2015
ADP-ribosylation factor and phosphatidic acid levels in Golgi membranes during budding of coatomer-coated vesicles
1998 StandoutNobel
Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia
1997 StandoutNobel
Interleukin 15: biology and relevance to human disease
2001
Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline
2017
Clinical Policy: Critical Issues in the Prescribing of Opioids for Adult Patients in the Emergency Department
2012
Cutaneous Hypoxia in Patients With Systemic Sclerosis (Scleroderma)
1988
Viscosupplementation for Osteoarthritis of the Knee
2012
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Intraarticular Sprifermin (Recombinant Human Fibroblast Growth Factor 18) in Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial
2014
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Current status and future prospects for disease modification in osteoarthritis
2017
Chimeric Antigen Receptor Therapy
2018 Standout
Global Molecular Effects of Tocilizumab Therapy in Rheumatoid Arthritis Synovium
2013
Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs
2014
Unresolved Questions in Rheumatology: Motion for Debate: Osteoarthritis Clinical Trials Have Not Identified Efficacious Therapies Because Traditional Imaging Outcome Measures Are Inadequate
2013
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Long-term opioid management for chronic noncancer pain
2010
Viscosupplementation for the treatment of osteoarthritis of the knee
2006
Guidelines for management of osteoarthritis published by the American College of Rheumatology and the European League Against Rheumatism: why are they so different?
2003
Opioids compared to placebo or other treatments for chronic low-back pain
2013
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
2008
Phospholipase D Stimulates Release of Nascent Secretory Vesicles from the trans-Golgi Network
1997
Aryl−Aryl Bond Formation One Century after the Discovery of the Ullmann Reaction
2002 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Reactivity of 3-Iodoimidazo[1,2-a]pyridines Using a Suzuki-Type Cross-Coupling Reaction
2000
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Knee osteoarthritis: should your patient opt for hyaluronic acid injection?
2006
Design of the Tocilizumab in Giant Cell Arteritis Trial
2013
Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib
2001
Works of André Beaulieu being referenced
The presence of meniscal lesions is a strong predictor of neuropathic pain in symptomatic knee osteoarthritis: a cross-sectional pilot study
2014
Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study
2013
Granulocyte macrophage-colony stimulating factor reduces the affinity of SHP-2 for the ITIM of CLECSF6 in neutrophils: A new mechanism of action for SHP-2
2005
Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
2014
Once‐Daily, Controlled‐Release Tramadol and Sustained‐Release Diclofenac Relieve Chronic Pain due to Osteoarthritis: A Randomized Controlled Trial
2008
Human Neutrophils Express the Interleukin-15 Receptor α Chain (IL-15Rα) but Not the IL-9Rα Component
1998
Efficacy and Tolerability Profile of Etoricoxib in Patients with Osteoarthritis: A Randomized, Double-blind, Placebo and Active-comparator Controlled 12-Week Efficacy Trial
2002
Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI
2011
Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee
2004
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study
2011
Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: A multicenter, randomized, double‐blind, placebo‐controlled study
2007
An Open-Label Pilot Study Evaluating by Magnetic Resonance Imaging the Potential for a Disease-Modifying Effect of Celecoxib Compared to a Modelized Historical Control Cohort in the Treatment of Knee Osteoarthritis
2010
A Randomized, Double‐Blind, Crossover Comparison of the Efficacy and Safety of Oral Controlled‐Release Tramadol and Placebo in Patients with Painful Osteoarthritis
2008
A Comparison of the Analgesic Efficacy of Tramadol Contramid OAD Versus Placebo in Patients with Pain Due to Osteoarthritis
2007
Efficacy and tolerability of lumiracoxib in the treatmentof osteoarthritis of the knee: A 13-week, randomized, double-blind comparison with celecoxib and placebo
2005
Low Molecular Weight GTP-binding Proteins in HL-60 Granulocytes
1995
A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain
2007
Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial
2000
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
2008
Buprenorphine Transdermal System for Opioid Therapy in Patients with Chronic Low Back Pain
2010
Increase in fibronectin in the deep dermis of involved skin in progressive systemic sclerosis
1979
Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial.
2004
Patient and Physician Expectations of Add‐On Treatment With Golimumab for Rheumatoid Arthritis: Relationships Between Expectations and Clinical and Quality of Life Outcomes
2014
Efficacy and safety of diacerein in osteoarthritis of the knee: A double-blind, placebo-controlled trial
2000
Total Knee Replacement as a Knee Osteoarthritis Outcome
2013
IgG Antibodies to Double‐Stranded DNA in Systemic Lupus Erythematosus Sera
1979
The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways
2008
The expression pattern of the ITIM-bearing lectin CLECSF6 in neutrophils suggests a key role in the control of inflammation
2002